Dublin, Jan. 25, 2017 -- Research and Markets has announced the addition of the "Global Genetic Testing Market Analysis & Trends - Industry Forecast to 2025" report to their offering.
The Global Genetic Testing Market is poised to grow at a CAGR of around 10.4% over the next decade to reach approximately $10.3 billion by 2025. Some of the prominent trends that the market is witnessing include increasing prevalence of infectious, chronic, and genetic diseases, rising market for personalized medicine, and encouraging legislative & regulatory policies.
On basis of test type the market is segmented by predictive & presymptomatic testing, diagnostic testing, carrier testing, prenatal testing, and new born screening.
By diseases the market is classified into thalassemia, sickle cell anemia, alzheimer's diseases, duchenne's muscular dystrophy, huntington's disease, cancer, cystic fibrosis, and other diseases.
Depending on the technology the market is segregated molecular testing, cytogenetic testing, and biochemical testing.
Based on application the market is categorized into cancer genetic testing, prenatal genetic testing, filling and capping machinery, pharmacogenomics genetic testing, and predisposition cancer genetic testing
This industry report analyzes the market estimates and forecasts for all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities;
- Market forecasts till 2025, using estimated market values as the base numbers;
- Key market trends across the business segments, Regions and Countries;
- Key developments and strategies observed in the market;
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends;
- In-depth company profiles of key players and upcoming prominent players;
- Growth prospects among the emerging nations through 2025;
- Market opportunities and recommendations for new investments.
Companies Mentioned:
- Abbott Laboratories
- Biocartis SA
- Applied Biosystems Inc.
- Celera Group
- AutoGenomics Inc.
- Roche Diagnostics Limited
- IntegraGen S.A
- Transgenomic, Inc.
- Molecular Inc.
- Luminex Corporation
- Quest Diagnostics Inc
- PerkinElmer Inc
- BioRad Laboratories
- ELITech Group
- Agilent Technologies Inc
- Thermo Fisher Scientific
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Genetic Testing Market, By Test Type
5 Genetic Testing Market, By Disease
6 Genetic Testing Market, By Technology
7 Genetic Testing Market, By Application
8 Genetic Testing Market, By Geography
9 Key Player Activities
10 Leading Companies
For more information about this report visit http://www.researchandmarkets.com/research/dgl4j6/global_genetic
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Genomics


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Italy Fines Apple €98.6 Million Over App Store Dominance
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



